FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3186386107> ?p ?o ?g. }

• W3186386107 endingPage "2958" @default.
• W3186386107 startingPage "2948" @default.
• W3186386107 abstract "PURPOSE Heightened regulations have decreased opioid prescribing across the United States, yet little is known about trends in opioid access among patients dying of cancer. METHODS Among 270,632 Medicare fee-for-service decedents with poor prognosis cancers, we used part D data to examine trends from 2007 to 2017 in opioid prescription fills and opioid potency (morphine milligram equivalents per day [MMED]) near the end-of-life (EOL), defined as the 30 days before death or hospice enrollment. We used administrative claims to evaluate trends in pain-related emergency department (ED) visits near EOL. RESULTS Between 2007 and 2017, the proportion of decedents with poor prognosis cancers receiving ≥ 1 opioid prescription near EOL declined 15.5% (relative percent difference [RPD]), from 42.0% (95% CI, 41.4 to 42.7) to 35.5% (95% CI, 34.9 to 36.0) and the proportion receiving ≥ 1 long-acting opioid prescription declined 36.5% (RPD), from 18.1% (95% CI, 17.6 to 18.6) to 11.5% (95% CI, 11.1 to 11.9). Among decedents receiving opioids near EOL, the mean daily dose fell 24.5%, from 85.6 MMED (95% CI, 82.9 to 88.3) to 64.6 (95% CI, 62.7 to 66.6) MMED. Overall, the total amount of opioids prescribed per decedent near EOL (averaged across those who did and did not receive an opioid) fell 38.0%, from 1,075 morphine milligram equivalents per decedent (95% CI, 1,042 to 1,109) to 666 morphine milligram equivalents per decedent (95% CI, 646 to 686). Simultaneously, the proportion of patients with pain-related ED visits increased 50.8% (RPD), from 13.2% (95% CI, 12.7 to 13.6) to 19.9% (95% CI, 19.4 to 20.4). Sensitivity analyses demonstrated similar declines in opioid utilization in the 60 and 90 days before death or hospice, and suggested that trends in opioid access were not confounded by secular trends in hospice utilization. CONCLUSION Opioid use among patients dying of cancer has declined substantially from 2007 to 2017. Rising pain-related ED visits suggests that EOL cancer pain management may be worsening." @default.
• W3186386107 created "2021-08-02" @default.
• W3186386107 creator A5029506227 @default.
• W3186386107 creator A5032378308 @default.
• W3186386107 creator A5046270355 @default.
• W3186386107 creator A5059793697 @default.
• W3186386107 creator A5066655122 @default.
• W3186386107 creator A5067575775 @default.
• W3186386107 date "2021-09-10" @default.
• W3186386107 modified "2023-10-12" @default.
• W3186386107 title "US Trends in Opioid Access Among Patients With Poor Prognosis Cancer Near the End-of-Life" @default.
• W3186386107 cites W1965144463 @default.
• W3186386107 cites W1973439845 @default.
• W3186386107 cites W1990355279 @default.
• W3186386107 cites W2005042033 @default.
• W3186386107 cites W2048292736 @default.
• W3186386107 cites W2056370494 @default.
• W3186386107 cites W2058804422 @default.
• W3186386107 cites W2070123858 @default.
• W3186386107 cites W2104258796 @default.
• W3186386107 cites W2108802610 @default.
• W3186386107 cites W2115016989 @default.
• W3186386107 cites W2115127702 @default.
• W3186386107 cites W2146526476 @default.
• W3186386107 cites W2157406381 @default.
• W3186386107 cites W2161824335 @default.
• W3186386107 cites W2162296777 @default.
• W3186386107 cites W2165183141 @default.
• W3186386107 cites W2189982580 @default.
• W3186386107 cites W2296986887 @default.
• W3186386107 cites W2329099948 @default.
• W3186386107 cites W2336000602 @default.
• W3186386107 cites W2337210803 @default.
• W3186386107 cites W2419332172 @default.
• W3186386107 cites W2466896638 @default.
• W3186386107 cites W2533477981 @default.
• W3186386107 cites W2589067153 @default.
• W3186386107 cites W2596617588 @default.
• W3186386107 cites W2725503094 @default.
• W3186386107 cites W2766210636 @default.
• W3186386107 cites W2791767313 @default.
• W3186386107 cites W2883699376 @default.
• W3186386107 cites W2889986002 @default.
• W3186386107 cites W2899291413 @default.
• W3186386107 cites W2911188335 @default.
• W3186386107 cites W2913098771 @default.
• W3186386107 cites W2913228683 @default.
• W3186386107 cites W2921118207 @default.
• W3186386107 cites W2922426486 @default.
• W3186386107 cites W2940825014 @default.
• W3186386107 cites W2942543957 @default.
• W3186386107 cites W3011193041 @default.
• W3186386107 cites W3021019063 @default.
• W3186386107 cites W3032300740 @default.
• W3186386107 cites W3062186532 @default.
• W3186386107 cites W3063884216 @default.
• W3186386107 cites W3134043436 @default.
• W3186386107 cites W4292521941 @default.
• W3186386107 doi "https://doi.org/10.1200/jco.21.00476" @default.
• W3186386107 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8425843" @default.
• W3186386107 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34292766" @default.
• W3186386107 hasPublicationYear "2021" @default.
• W3186386107 type Work @default.
• W3186386107 sameAs 3186386107 @default.
• W3186386107 citedByCount "46" @default.
• W3186386107 countsByYear W31863861072021 @default.
• W3186386107 countsByYear W31863861072022 @default.
• W3186386107 countsByYear W31863861072023 @default.
• W3186386107 crossrefType "journal-article" @default.
• W3186386107 hasAuthorship W3186386107A5029506227 @default.
• W3186386107 hasAuthorship W3186386107A5032378308 @default.
• W3186386107 hasAuthorship W3186386107A5046270355 @default.
• W3186386107 hasAuthorship W3186386107A5059793697 @default.
• W3186386107 hasAuthorship W3186386107A5066655122 @default.
• W3186386107 hasAuthorship W3186386107A5067575775 @default.
• W3186386107 hasBestOaLocation W31863861071 @default.
• W3186386107 hasConcept C126322002 @default.
• W3186386107 hasConcept C170493617 @default.
• W3186386107 hasConcept C194828623 @default.
• W3186386107 hasConcept C2426938 @default.
• W3186386107 hasConcept C2777389121 @default.
• W3186386107 hasConcept C2781063702 @default.
• W3186386107 hasConcept C71924100 @default.
• W3186386107 hasConcept C98274493 @default.
• W3186386107 hasConceptScore W3186386107C126322002 @default.
• W3186386107 hasConceptScore W3186386107C170493617 @default.
• W3186386107 hasConceptScore W3186386107C194828623 @default.
• W3186386107 hasConceptScore W3186386107C2426938 @default.
• W3186386107 hasConceptScore W3186386107C2777389121 @default.
• W3186386107 hasConceptScore W3186386107C2781063702 @default.
• W3186386107 hasConceptScore W3186386107C71924100 @default.
• W3186386107 hasConceptScore W3186386107C98274493 @default.
• W3186386107 hasIssue "26" @default.
• W3186386107 hasLocation W31863861071 @default.
• W3186386107 hasLocation W31863861072 @default.
• W3186386107 hasLocation W31863861073 @default.
• W3186386107 hasOpenAccess W3186386107 @default.
• W3186386107 hasPrimaryLocation W31863861071 @default.

• next